Analyzing Online Conversations: What Social Media Can Teach Us about the Patient Journey

Click Here to listen On-Demand

Healthcare consumers are flocking to the social Web to post about their experiences with a given disease and the treatments they hope will help fight it. State-of-the-art search software is available to capture and process these conversations, meaning pharma has access to a wealth of consumer dialogues. Yet ‘listening' to patients doesn't mean we're hearing them. Jeff Greene and Susan Eno Collins will present findings from a mining effort of thousands of online conversations about rheumatoid arthritis, along with the implications for brands across every disease category.

Jeff and Susan will use this example to answer questions about:

·         What is the patient journey and how can it inform communications planning for pharma brands?

·         How can online conversations help us understand the patient journey for a given disease?

·         What are some common barriers to treatment, and how did we find them on the Web?

·         How can brands identify knowledge gaps or myths and address them through patient education?

Speakers:

Susan Eno Collins, SVP, health education research and development, HealthEd

Jeff Greene, director of strategic services, social media, HealthEd

Moderator
James Chase,
Editor in Chief, MM&M

Sponsored by HealthEd

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.